Archive · 15 Dec 2025
Corona Remedies Shares List at 38% Premium
Corona Remedies is a company that makes medicines.
When it started selling shares to the public for the first time, the shares were much more expensive than expected.
People who bought the shares at the starting price made a lot of money right away because the shares were worth 38% more when they started trading.
This happened because many people wanted to buy shares in good medicine companies, and there aren't many of them available.
Corona Remedies shares listed at Rs 1,470 on NSE and Rs 1,452 on BSE, a 38% premium over the IPO issue price of Rs 1,062.
The strong listing performance reflects high investor demand for quality pharmaceutical stocks.
The company's debut was one of the more notable in recent months.
The premium listing indicates a scarcity value for quality pharma names.
Investors are advised to consider holding or selling based on market conditions and personal financial goals.
- Who
- Corona Remedies
- What
- Shares listed at a 38% premium
- When
- Not specified
- Where
- National Stock Exchange (NSE) and Bombay Stock Exchange (BSE)
- Why
- Strong investor demand and scarcity of quality pharma stocks
- Company
- Corona Remedies
- Listing Price (NSE)
- Rs 1,470
- Listing Price (BSE)
- Rs 1,452
- IPO Issue Price
- Rs 1,062
- Listing Gain
- 38%
- Sector
- Pharmaceuticals
